期刊文献+

垂体腺瘤的侵袭性与解剖学基础 被引量:7

下载PDF
导出
摘要 侵袭性垂体腺瘤(IPA)因其侵袭性生长,手术全切率低,复发率高,治疗非常困难,其主要依靠影像学、术中所见和术后病理。三者所采用的标准不同,诊断差异性很大。蝶窦的气化程度、鞍膈的坚厚程度和鞍膈孔的大小、海绵窦内侧壁先天缺如或缺损等因素都会影响垂体腺瘤的生长,因此,解剖结构是垂体腺瘤侵袭性生长的解剖学基础。
出处 《中国微侵袭神经外科杂志》 CAS 2015年第1期43-45,共3页 Chinese Journal of Minimally Invasive Neurosurgery
基金 首都卫生发展基金(编号:首发2011-4001-06)
  • 相关文献

参考文献25

  • 1李军,牛朝诗.侵袭性垂体腺瘤的研究进展[J].中国微侵袭神经外科杂志,2007,12(11):523-525. 被引量:2
  • 2Jefferson G.Extrasellar extensions of pituitary adenomas:(Section of Neurology)[J].Proc R Soc Med,1940,33(7):433-458.
  • 3Hornyak M,Couldwell WT.Multimodality treatment for invasive pituitary adenomas[J].Postgrad Med,2009,121(2):168-176.
  • 4Kaltsas GA,Nomikos P,Kontogeorgos G,et al.Clinical review:diagnosis and management of pituitary carcinomas[J].J Clin Endocrinol Metab,2005,90(5):3089-3099.
  • 5龚俊扬,史继新,杭春华,成惠林,印红霞,刘承基,谭启富,邬祖良.侵袭性垂体腺瘤的生物学特性研究──临床、病理、细胞动力学研究[J].中国微侵袭神经外科杂志,1999,4(4):31-33. 被引量:2
  • 6Oh MC,Tihan T,Kunwar S,et al.Clinical management of pituitary carcinomas[J].Neurosurg Clin N Am,2012,23(4):595-606.
  • 7Zada G,Woodmansee WW,Ramkissoon S,et al.Atypical pituitary adenomas:incidence,clinical characteristics,and implications[J].J Neurosurg,2011,114(2):336-344.
  • 8魏俊吉,张波,王任直,徐淑军,马文斌.侵袭性垂体腺瘤发病机制及诊断标准的研究进展[J].中国微侵袭神经外科杂志,2005,10(10):478-480. 被引量:13
  • 9Knosp E,Steiner E,Kitz K,et al.Pituitary adenomas with invasive of the cavernous sinus space:magnetic resononance imaging classification compared with surgical findings[J].Neurosurgery,1993,33(4):610-617.
  • 10Hardy J,Vezina JL.Transsphenoidal neurosurgery of intracranial neoplasm[J].Adv Neurol,1976,15:261-273.

二级参考文献101

共引文献38

同被引文献64

  • 1王任直.垂体腺瘤的规范化诊断和治疗[J].中华神经外科杂志,2006,22(6):325-326. 被引量:47
  • 2张玉海,杨允学,徐厚池,付海霞,丁伟,鲍文公.GGF、PCNA与垂体瘤侵袭性关系探讨[J].中华神经外科疾病研究杂志,2007,6(4):330-333. 被引量:5
  • 3Saeger W, Ludecke DK, Buchfelder M, et al. Pathohistolo-gical classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry [J]. Eur J Endo- crinol, 2007, 156(2): 203-216.
  • 4Verhelst J, Abs R, Maiter D, et al. Cabergoline in the treatment ofhyperprolactinemia: a study in 455 patients [J]. J Clin Endocrinol Metab, 1999, 84(7): 2518-2522.
  • 5Wu ZB, Zheng WM, Su ZP, et al. Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correla- tion with the response to bromocriptine and with tumor biological behavior [J]. J Neurooncol, 2010, 99(1 ): 25 -32.
  • 6Gooren L J, Assies J, Asscheman H, et al. Estrogen-induced prolactinoma in a man [J]. J Clin Endocrinol Metab, 1988, 66(2): 444-446.
  • 7Garcia MM, Kapcala LP. Growth of a microprolactinoma to a rnacroprolactinoma during estrogen therapy [J]. J Endo- crinol Invest, 1995, 18(6): 450-455.
  • 8Lv H, Li C, Gui S, et al. Expression of estrogen receptor et and growth factors in human prolactinoma and its correlation with clinical features and gender [J]. J Endocrinol Invest, 2012, 35(2): 174-180.
  • 9Manoranjan B, Salehi F, Scheithauer BW, et al. Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas [J]. Anticancer Res, 2010, 30(7): 2897-2904.
  • 10Heaney AP, Femando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis [J]. J Clin Invest, 2002, 109(2): 277-283.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部